Association of PD-L1 Expression and Other Variables With Benefit From Immune Checkpoint Inhibition in Advanced Gastroesophageal Cancer: Systematic Review and Meta-analysis of 17 Phase 3 Randomized Clinical Trials.

Association of PD-L1 Expression and Other Variables With Benefit From Immune Checkpoint Inhibition in Advanced Gastroesophageal Cancer: Systematic Review and Meta-analysis of 17 Phase 3 Randomized Clinical Trials. JAMA Oncol. 2022 10 01; 8(10):1456-1465.

View in: PubMed

subject areas

Adenocarcinoma
Adult
B7-H1 Antigen
Clinical Trials, Phase III as Topic
Esophageal Neoplasms
Female
Humans
Male
Microsatellite Instability
Randomized Controlled Trials as Topic
Stomach Neoplasms
United States

authors with profiles

JAFFER A AJANI